Each year in BC approximately 1,000 new cases of blood diseases including leukemia, myeloma are diagnosed in adults. The number is increasing; the incidence of blood diseases is on the rise as a result of society’s aging population and longer lifespans.

The VGH-based team of medical experts that make up the Leukemia/Bone Marrow Transplant Program of BC provide the specialized care and treatment required by their patients. People from all over the province come to VGH for the best and most progressive care and treatment for blood diseases.

The Program’s research component – the Hematology Research Clinical Trials Unit (HRCTU) – provides the scientists and medical experts pursuing blood disease research with the support they need to develop and test new treatment options for patients. Through HRCTU clinical trials, hundreds of blood disease patients in British Columbia get access to new, improved, and potentially life-saving treatment options that would otherwise be unavailable to them.

Many aspects of the Program’s patient care and research efforts are in great need of donor support. A gift from you could help improve the quality and quantity of treatment options available for adults confronted with a blood disease diagnosis.